Introduction: We tested two treatment strategies to determine: treatment (a) prognosis (seizure frequency, mortality, suicide, and complications), (b) safety and adherence of treatment, (c) self-reported satisfaction with treatment and self-reported productivity, and policy aspects (a) number of required tablets for universal treatment (NRT), (b) cost of management, (c) manpower-gap and requirements for scaling-up of epilepsy care. Methods: We performed a random-cluster survey (N = 16510) and identified 96 cases ($1 year of age) in 24 villages. The
Purpose: Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of l...
International audiencePURPOSE: We conducted a population-based study of epilepsy in Prey Veng (Cambo...
Background: Epilepsy is a common disease but to achieve successful seizure control in developing cou...
We tested two treatment strategies to determine: treatment (a) prognosis (seizure frequency, mortali...
International audienceINTRODUCTION: We tested two treatment strategies to determine: treatment (a) p...
International audienceBackgroundEpilepsy affects more than 50 million people worldwide, 80% of whom ...
International audienceBackgroundEpilepsy affects more than 50 million people worldwide, 80% of whom ...
Background: Epilepsy affects more than 50 million people worldwide, 80% of whom live in low- and mid...
Background: Epilepsy affects more than 50 million people worldwide, 80% of whom live in low- and mid...
Background: Epilepsy affects more than 50 million people worldwide, 80% of whom live in low- and mid...
Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of life (QOL)...
International audiencePURPOSE: Identify epilepsy-associated factors and calculate measures of impact...
International audiencePurpose:The prevalence of epilepsy is 7.7& in Laos and 5.8 & in Cambodia, the ...
International audiencePURPOSE: To estimate the lifetime prevalence of epilepsy in Prey Veng province...
International audienceBackgroundThe prevalence of epilepsy is 7.7‰ in Laos and 5.8‰ in Cambodia, and...
Purpose: Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of l...
International audiencePURPOSE: We conducted a population-based study of epilepsy in Prey Veng (Cambo...
Background: Epilepsy is a common disease but to achieve successful seizure control in developing cou...
We tested two treatment strategies to determine: treatment (a) prognosis (seizure frequency, mortali...
International audienceINTRODUCTION: We tested two treatment strategies to determine: treatment (a) p...
International audienceBackgroundEpilepsy affects more than 50 million people worldwide, 80% of whom ...
International audienceBackgroundEpilepsy affects more than 50 million people worldwide, 80% of whom ...
Background: Epilepsy affects more than 50 million people worldwide, 80% of whom live in low- and mid...
Background: Epilepsy affects more than 50 million people worldwide, 80% of whom live in low- and mid...
Background: Epilepsy affects more than 50 million people worldwide, 80% of whom live in low- and mid...
Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of life (QOL)...
International audiencePURPOSE: Identify epilepsy-associated factors and calculate measures of impact...
International audiencePurpose:The prevalence of epilepsy is 7.7& in Laos and 5.8 & in Cambodia, the ...
International audiencePURPOSE: To estimate the lifetime prevalence of epilepsy in Prey Veng province...
International audienceBackgroundThe prevalence of epilepsy is 7.7‰ in Laos and 5.8‰ in Cambodia, and...
Purpose: Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of l...
International audiencePURPOSE: We conducted a population-based study of epilepsy in Prey Veng (Cambo...
Background: Epilepsy is a common disease but to achieve successful seizure control in developing cou...